Identification of a Novel Three-immunogene Diagnostic Signature for Alopecia Areata

Overview

Journal Ann Dermatol

Date 2025 Feb 2

PMID 39894670

Authors

Xiuwen Chen

Wenzi Liang

Changmin Lin

Yike Lin

Affiliations

Soon will be listed here.

Abstract

Background: Autoimmune mechanisms have important roles in the pathogenesis of alopecia areata (AA).

Objective: This study aimed to evaluate the exact biological and clinical importance of immunogenes in AA patients using bioinformatic methods.

Methods: Five AA scalp gene expression profiles were obtained from the Gene Expression Omnibus database. Differentially-expressed genes (DEGs) between AA and control groups were identified. An immune-related gene diagnostic signature (IRGDS) was established by protein-protein interaction network analysis, least absolute shrinkage and selection operator and logistic regression analysis.

Results: A total of 102 immune-related DEGs were identified. We developed an IRGDS composed of CD8A, CSF1R and CXCL10 for AA molecular pathological assessment and diagnosis (area under the receiver operating characteristic curve [AUC]=0.962). We also validated the diagnostic value of the IRGDS in an external cohort (AUC=0.955). Patients with high IRGDS scores presented with a higher abundance of immune cell infiltration and expression of genes associated with immune recruitment and immune activation, suggesting adverse biological alterations.

Conclusion: In our study, an IRGDS model with accurately diagnostic capacity for AA was established, and biological alterations were deciphered in AA. The IRGDS may be used as an auxiliary diagnostic marker for AA.

References

Alkhalifah A, Alsantali A, Wang E, McElwee K, Shapiro J . Alopecia areata update: part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol. 2010; 62(2):177-88, quiz 189-90. DOI: 10.1016/j.jaad.2009.10.032. View

Dubin C, Glickman J, Del Duca E, Chennareddy S, Han J, Dahabreh D . Scalp and serum profiling of frontal fibrosing alopecia reveals scalp immune and fibrosis dysregulation with no systemic involvement. J Am Acad Dermatol. 2021; 86(3):551-562. DOI: 10.1016/j.jaad.2021.05.016. View

Richmond J, Bangari D, Essien K, Currimbhoy S, Groom J, Pandya A . Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of Disease. J Invest Dermatol. 2016; 137(2):350-358. PMC: 5258673. DOI: 10.1016/j.jid.2016.09.016. View

Tokunaga R, Zhang W, Naseem M, Puccini A, Berger M, Soni S . CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy. Cancer Treat Rev. 2017; 63:40-47. PMC: 5801162. DOI: 10.1016/j.ctrv.2017.11.007. View

Bertolini M, McElwee K, Gilhar A, Bulfone-Paus S, Paus R . Hair follicle immune privilege and its collapse in alopecia areata. Exp Dermatol. 2020; 29(8):703-725. DOI: 10.1111/exd.14155. View

Yuan X, Tang Y, Zhao Z, Liu F, Shi W, Zhang Y . Identification and verification of EOMEs regulated network in Alopecia areata. Int Immunopharmacol. 2020; 84:106544. DOI: 10.1016/j.intimp.2020.106544. View

Sato-Kawamura M, Aiba S, Tagami H . Strong expression of CD40, CD54 and HLA-DR antigen and lack of evidence for direct cellular cytotoxicity are unique immunohistopathological features in alopecia areata. Arch Dermatol Res. 2003; 294(12):536-43. DOI: 10.1007/s00403-002-0354-7. View

Chauchet X, Cons L, Chatel L, Daubeuf B, Didelot G, Moine V . CD47xCD19 bispecific antibody triggers recruitment and activation of innate immune effector cells in a B-cell lymphoma xenograft model. Exp Hematol Oncol. 2022; 11(1):26. PMC: 9088114. DOI: 10.1186/s40164-022-00279-w. View

Smit M, Verdijk P, van der Raaij-Helmer E, Navis M, Hensbergen P, Leurs R . CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase C-dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase. Blood. 2003; 102(6):1959-65. DOI: 10.1182/blood-2002-12-3945. View

10.

Fuentes-Duculan J, Gulati N, Bonifacio K, Kunjravia N, Zheng X, Suarez-Farinas M . Biomarkers of alopecia areata disease activity and response to corticosteroid treatment. Exp Dermatol. 2015; 25(4):282-6. DOI: 10.1111/exd.12918. View

11.

Ito T, Hashizume H, Shimauchi T, Funakoshi A, Ito N, Fukamizu H . CXCL10 produced from hair follicles induces Th1 and Tc1 cell infiltration in the acute phase of alopecia areata followed by sustained Tc1 accumulation in the chronic phase. J Dermatol Sci. 2013; 69(2):140-7. DOI: 10.1016/j.jdermsci.2012.12.003. View

12.

Dy L, Whiting D . Histopathology of alopecia areata, acute and chronic: Why is it important to the clinician?. Dermatol Ther. 2011; 24(3):369-74. DOI: 10.1111/j.1529-8019.2011.01414.x. View

13.

Xuan W, Qu Q, Zheng B, Xiong S, Fan G . The chemotaxis of M1 and M2 macrophages is regulated by different chemokines. J Leukoc Biol. 2014; 97(1):61-9. DOI: 10.1189/jlb.1A0314-170R. View

14.

Ferrari S, Paparo S, Ragusa F, Elia G, Mazzi V, Patrizio A . Chemokines in thyroid autoimmunity. Best Pract Res Clin Endocrinol Metab. 2023; 37(2):101773. DOI: 10.1016/j.beem.2023.101773. View

15.

Gregoriou S, Papafragkaki D, Kontochristopoulos G, Rallis E, Kalogeromitros D, Rigopoulos D . Cytokines and other mediators in alopecia areata. Mediators Inflamm. 2010; 2010:928030. PMC: 2837895. DOI: 10.1155/2010/928030. View

16.

Shimizu T, Mizue Y, Abe R, Watanabe H, Shimizu H . Increased macrophage migration inhibitory factor (MIF) in the sera of patients with extensive alopecia areata. J Invest Dermatol. 2002; 118(3):555-7. DOI: 10.1046/j.0022-202x.2001.01669.x. View

17.

Strazzulla L, Chun Wang E, Avila L, Lo Sicco K, Brinster N, Christiano A . Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol. 2017; 78(1):1-12. DOI: 10.1016/j.jaad.2017.04.1141. View

18.

Charoentong P, Finotello F, Angelova M, Mayer C, Efremova M, Rieder D . Pan-cancer Immunogenomic Analyses Reveal Genotype-Immunophenotype Relationships and Predictors of Response to Checkpoint Blockade. Cell Rep. 2017; 18(1):248-262. DOI: 10.1016/j.celrep.2016.12.019. View

19.

Karin N . CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond. Front Immunol. 2020; 11:976. PMC: 7274023. DOI: 10.3389/fimmu.2020.00976. View